10-13229614-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145314.3(UCMA):c.316G>A(p.Asp106Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00013 in 1,613,642 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145314.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UCMA | NM_145314.3 | c.316G>A | p.Asp106Asn | missense_variant | 4/5 | ENST00000378681.8 | NP_660357.2 | |
UCMA | NM_001303118.2 | c.220G>A | p.Asp74Asn | missense_variant | 3/4 | NP_001290047.1 | ||
UCMA | NM_001303119.2 | c.154G>A | p.Asp52Asn | missense_variant | 2/3 | NP_001290048.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000407 AC: 62AN: 152180Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000215 AC: 54AN: 251194Hom.: 0 AF XY: 0.000236 AC XY: 32AN XY: 135760
GnomAD4 exome AF: 0.000101 AC: 147AN: 1461462Hom.: 0 Cov.: 30 AF XY: 0.000124 AC XY: 90AN XY: 727040
GnomAD4 genome AF: 0.000407 AC: 62AN: 152180Hom.: 0 Cov.: 31 AF XY: 0.000363 AC XY: 27AN XY: 74344
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 06, 2024 | The c.316G>A (p.D106N) alteration is located in exon 4 (coding exon 4) of the UCMA gene. This alteration results from a G to A substitution at nucleotide position 316, causing the aspartic acid (D) at amino acid position 106 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at